Medical News

RSS

Drug registration process for Nutra Pharma's pain reliever begins

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Canada and Europe for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.

22 Sep 2009

Veterans Healing Initiative formed for veterans suffering from PTSD

The Veterans Healing Initiative (VHI) has been formed in response to the dramatic increase of Substance Abuse (SA) and co-occurring mental health disorders among U.S. Veterans. Formed by Margaret Stone and James L. Abernathy, VHI's core mission is to raise funds for veterans who need treatment for Addiction and Post Traumatic Stress Disorder (PTSD) and help them begin to heal the war within.

22 Sep 2009

Model-Based Design reduces the development time of FES devices

The MathWorks today announced that the Cleveland FES Center, using tools for Model-Based Design, has developed research technology that more quickly restores movement to individuals with neuromuscular disabilities.

22 Sep 2009

ID-ONE Cosmo dual interface card for multiple secure applications launched by Oberthur Technologies

Oberthur Technologies, a global leader in the delivery of high security solutions and the #1 provider of credentials to the U.S. Federal government, announces the availability of its dual interface ID-ONE™ Cosmo card to the Corporate Market at the ASIS International 55th Annual Seminar, September 21-24 at the Anaheim Convention Center in Anaheim, CA.

22 Sep 2009

Interactive Health Insurance Buyer's Guide launched

Today, eHealthInsurance launched a new Interactive Health Insurance Buyer's Guide. Designed for consumers considering all of their options during the traditional open enrollment season, the interactive tool helps consumers make informed decisions when buying their own health coverage.

22 Sep 2009

Late diagnosis of bipolar disorder in children and adults

75% of the cases of paediatric bipolar disorder are diagnosed late - up to 18 months - due to the symptoms manifesting themselves in a different manner depending on whether the patient is a child or adult. Moreover, 25% of sufferers have a delay in their medical diagnoses of up to three years and four months, according to a study by the Department of Psychiatry and Medical Psychology at the University Hospital of Navarra, in collaboration with the Paediatric Psychopharmacology Unit at the l Massachusetts General Hospital at Harvard University (Boston, United States).

22 Sep 2009

Nasdaq issues Repros Therapeutics a second delisting notice

Repros Therapeutics (NasdaqGM:RPRX) today announced that on September 15, 2009, the Company received a second letter from The Nasdaq Stock Market advising that, in addition to the deficiencies previously disclosed on August 17, 2009, the Company’s market value of publicly held shares was below the minimum $15,000,000 requirement for continued listing on the Nasdaq Global Market by Listing Rule 5450(b)(2)(C) or 5450(b)(3)(C).

22 Sep 2009

Amorfix announces 100% specificity upon testing 10,000 blood donations for vCJD

Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 10,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD"). with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.

22 Sep 2009

PMCC purchases NextGen EHR and EPM software licenses

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of ambulatory healthcare and connectivity solutions, today announced that Piedmont Medical Care Corporation (PMCC), the administrative arm of the non-cardiology physician practice entities of Piedmont Healthcare (PHC), has purchased an additional 230 “bundled” NextGen Electronic Health Record (EHR) and NextGen Enterprise Practice Management (EPM) software licenses.

22 Sep 2009

FemSoft from Rochester Medical included in the UK Drug Tariff

Rochester Medical Corporation (Nasdaq: ROCM) today announced that the Company's FemSoft(R) Insert has been approved for inclusion in Part IX of the UK Drug Tariff as a prescription product which is reimbursable.

22 Sep 2009

WDS conducts free skin cancer screenings

In the most concentrated effort to promote sun safety and skin cancer prevention in the 35-year history of the Women's Dermatologic Society (WDS), volunteer dermatologists in three states recently provided free skin cancer screenings and sun safety education to spectators, professional athletes and media members at four major golf and tennis events throughout the month of August.

22 Sep 2009

CGI commitment to Action improves health services in Rwanda and Haiti

Management Sciences for Health (MSH) today reported that the first year of its four-year $12.5 million CGI Commitment to Action to introduce and expand Performance-Based Financing (PBF) has resulted in dramatically improved quality and delivery of health services for millions of people in Rwanda and Haiti. PBF empowers health managers to allocate resources in a way that rewards meeting health goals. By improving financial management capacity and expertise, PBF strengthens the sustainability and performance of ministries of health, district and community institutions, and NGOs.

22 Sep 2009

Report on evidence-based disease prevention programs released by TFAH and NYAM

Trust for America's Health (TFAH) and The New York Academy of Medicine (NYAM) released a new report today featuring a range of evidence-based disease prevention programs that have shown results for improving health and reducing costs in communities.

22 Sep 2009

Nasdaq issues Urologix a Staff Deficiency Letter

Urologix®, Inc. (NASDAQ:ULGX), received a Staff Deficiency Letter from The Nasdaq Stock Market on September 17, 2009, stating that the Company’s stockholders’ equity at June 30, 2009 was less than the $10 million minimum required for continued listing on The Nasdaq Global Market under Marketplace Rule 5450(b)(1)(A).

22 Sep 2009

T-System revises its H1N1 point-of-care charting templates

T-System, Inc., the nation's largest provider of emergency department (ED) clinical documentation tools, today announced it has issued revised H1N1 point-of-care charting templates reflecting the most recent recommendations of the Centers for Disease Control and Prevention (CDC).

22 Sep 2009

Certification program for graduates to teach free community yoga classes

Yoga South announced it will include a lesson in the value of giving with its yoga certification program by encouraging graduates to teach free community yoga classes, according to Yoga South's Owner James Kigar and Director of Teacher Training Judy Weaver.

22 Sep 2009

Small business operators worried over proposed health care legislation

The U.S. Congress is back in session with Health Care legislation dominating the attention of lawmakers and the public. The current proposed health care legislation will mandate small business with payrolls more than $250,000 to provide health insurance to their workers or pay a fine.

22 Sep 2009

"Help is Here Express" bus tour in South Carolina to provide prescription medicines for free

The "Help is Here Express" bus tour will be stopping in South Carolina throughout the week of September 21 - 25 at various cities in order to help uninsured and financially struggling South Carolinians access information on programs that provide prescription medicines for free or nearly free. With the state's unemployment rate now hitting 11.8 percent, the Partnership for Prescription Assistance (PPA) bus tour is raising awareness of patient assistance programs among state residents who face layoffs and loss of health care benefits.

22 Sep 2009

Researchers to present results of HORIZONS-AMI trial at TCT scientific symposium

Two subset analyses from the landmark HORIZONS-AMI trial show that the anticoagulant bivalirudin lowers major bleeding and cardiac death versus the combination of heparin and a GP IIb/IIIa inhibitor in patients with ST-segment myocardial infarction (STEMI) who have disease of the left anterior descending artery (LAD), while in STEMI patients at highest risk for death, bivalirudin also confers the greatest mortality benefit.

22 Sep 2009

StemCells to take part in international networking event

StemCells, Inc. (NASDAQ:STEM) announced today its participation in the 2009 World Stem Cell Summit to be held September 21 – 23 in Baltimore, Maryland.

22 Sep 2009